Loading clinical trials...
Loading clinical trials...
Hepatitis B Virus (HBV) Antibody (Anti-HBs) Booster Program for the Production of Hepatitis B Immune Globulin (HBIG)
Conditions
Interventions
hepatitis B vaccine
hepatitis B vaccine
Locations
2
United States
Cangene Plasma Resources, Mid-Florida
Altamonte Springs, Florida, United States
Cangene Plasma Resources, Frederick
Frederick, Maryland, United States
Start Date
September 1, 2009
Primary Completion Date
March 11, 2011
Completion Date
March 11, 2011
Last Updated
March 18, 2024
NCT07310264
NCT06342713
NCT07472361
NCT06649110
NCT06823947
NCT07240675
Lead Sponsor
Emergent BioSolutions
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions